These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9236625)

  • 1. Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy.
    Govoni V; Granieri E; Tola MR; Paolino E; Casetta I; Fainardi E; Monetti VC
    Brain; 1997 Jul; 120 ( Pt 7)():1123-30. PubMed ID: 9236625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a decrease in Guillain-Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy.
    Govoni V; Granieri E; Manconi M; Capone J; Casetta I
    J Neurol Sci; 2003 Dec; 216(1):99-103. PubMed ID: 14607309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome and ganglioside therapy in Italy.
    Raschetti R; Maggini M; Popoli P
    Lancet; 1992 Jul; 340(8810):60. PubMed ID: 1351644
    [No Abstract]   [Full Text] [Related]  

  • 4. Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association.
    Granieri E; Casetta I; Govoni V; Tola MR; Paolino E; Rocca WA
    Neuroepidemiology; 1991; 10(4):161-9. PubMed ID: 1745325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of Guillain-Barre syndrome in Ferrara, Italy: is the disease really increasing?
    Govoni V; Granieri E; Casetta I; Tola MR; Paolino E; Fainardi E; Monetti VC
    J Neurol Sci; 1996 Apr; 137(1):62-8. PubMed ID: 9120489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gangliosides and Guillain-Barré syndrome.
    Raschetti R; Maggini M; Popoli P; Caffari B; Da Cas R; Menniti-Ippolito F; Spila-Alegiani S; Traversa G
    J Clin Epidemiol; 1995 Nov; 48(11):1399-405. PubMed ID: 7490603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome after exogenous gangliosides in Italy.
    Landi G; D'Alessandro R; Dossi BC; Ricci S; Simone IL; Ciccone A
    BMJ; 1993 Dec; 307(6917):1463-4. PubMed ID: 8281088
    [No Abstract]   [Full Text] [Related]  

  • 8. Gangliosides and Guillain-Barré syndrome. Apparent association is a coincidence.
    Grigoletto F
    BMJ; 1994 Mar; 308(6929):653-4. PubMed ID: 8148725
    [No Abstract]   [Full Text] [Related]  

  • 9. Exposure to exogenous gangliosides and Guillain-Barré syndrome.
    Beghi E
    Neuroepidemiology; 1995; 14(2):45-8. PubMed ID: 7891813
    [No Abstract]   [Full Text] [Related]  

  • 10. Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.
    Clinical E; Neurology EP
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):218-24. PubMed ID: 9703176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of the Guillain-Barré syndrome in Ferrara, northern Italy, 1981-1987.
    Paolino E; Govoni V; Tola MR; Casetta I; Granieri E
    Neuroepidemiology; 1991; 10(3):105-11. PubMed ID: 1922642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between parenteral gangliosides administration and the Guillain-Barré syndrome].
    Conceição I; Carvalho M; Alves M; Parreira E; Martins A; Ferro J; Sales-Luis ML
    Rev Neurol; 1999 Jun 1-15; 28(11):1033-5. PubMed ID: 10390766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence study of Guillain-Barré syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up.
    Granieri E; Andreasi NG; De Martin P; Govoni V; Castellazzi M; Cesnik E; Pugliatti M; Casetta I
    Neurol Sci; 2019 Mar; 40(3):603-609. PubMed ID: 30617450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gangliosides and Guillain-Barré syndrome: the Spanish data.
    Díez-Tejedor E; Gutiérrez-Rivas E; Gil-Peralta A
    Neuroepidemiology; 1993; 12(5):251-6. PubMed ID: 8309499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gangliosides and Guillain-Barré syndrome. No causal link.
    Samson JC; Fiori MG
    BMJ; 1994 Mar; 308(6929):653. PubMed ID: 8148723
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
    Illa I; Ortiz N; Gallard E; Juarez C; Grau JM; Dalakas MC
    Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of clinical variants of Guillain-Barré syndrome in Ferrara, Italy.
    Govoni V; Granieri E; Tola MR; Casetta I; Ruppi P; Vaghi L
    J Neurol; 1999 Nov; 246(11):1010-4. PubMed ID: 10631631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence.
    Rantala H; Cherry JD; Shields WD; Uhari M
    J Pediatr; 1994 Feb; 124(2):220-3. PubMed ID: 8301426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of Guillain-Barré syndrome postpartum.
    Cheng Q; Jiang GX; Fredrikson S; Link H; de Pedro-Cuesta J
    Epidemiology; 1998 Nov; 9(6):601-4. PubMed ID: 9799167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group.
    Safranek TJ; Lawrence DN; Kurland LT; Culver DH; Wiederholt WC; Hayner NS; Osterholm MT; O'Brien P; Hughes JM
    Am J Epidemiol; 1991 May; 133(9):940-51. PubMed ID: 1851395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.